Showing results (41-50 of 68) with videos related to
Sort By:
Pageof 7
Journal of Managed Care & Specialty Pharmacy|September 25, 2019
Persistence with Basal-Bolus Insulin Therapy in Patients with Type 2 Diabetes Mellitus and Effect on Clinical and Economic Outcomes: A Retrospective Claims Database StudySteven V Edelman, Anastasia Ermakova, Yan Xiong, et al.Clinical Diabetes : a Publication of the American Diabetes Association|July 31, 2025
Impact of Continuous Glucose Monitoring Sourcing on Real-World Adherence and Health Care Costs: A Comparative Analysis by Insurance TypeJason C Allaire, Consuela Dennis, Eugene E Wright, et al.Advances in Therapy|July 8, 2016
Making Insulin Accessible: Does Inhaled Insulin Fill an Unmet Need?Janet B McGill, David Ahn, Steven V Edelman, et al.Diabetes Technology & Therapeutics|June 28, 2003
Serum 1,5-anhydroglucitol (GlycoMark ): a short-term glycemic markerJohn B Buse, Jennifer L R Freeman, Steven V Edelman, et al.Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|September 5, 2015
BIOSIMILARS AND NEW INSULIN VERSIONSAnne L Peters, R Daniel Pollom, Jason S Zielonka, et al.The Diabetes Educator|August 24, 2010
Are patients' initial experiences at the diagnosis of type 2 diabetes associated with attitudes and self-management over time?William H Polonsky, Lawrence Fisher, Susan Guzman, et al.Current Medical Research and Opinion|June 4, 2014
Testing versus guessing blood glucose values: impact on self-care behaviors in type 2 diabetesJeremy Pettus, Patricia Stenger, Holly C Schachner, et al.Journal of Diabetes Science and Technology|September 2, 2011
A 16-week open-label, multicenter pilot study assessing insulin pump therapy in patients with type 2 diabetes suboptimally controlled with multiple daily injectionsJuan P Frias, Bruce W Bode, Timothy S Bailey, et al.Diabetes Care|August 13, 2017
Understanding the Gap Between Efficacy in Randomized Controlled Trials and Effectiveness in Real-World Use of GLP-1 RA and DPP-4 Therapies in Patients With Type 2 DiabetesGinger S Carls, Edward Tuttle, Ruo-Ding Tan, et al.The Journal of Clinical Endocrinology and Metabolism|October 16, 2004
Skeletal muscle GLUT1 transporter protein expression and basal leg glucose uptake are reduced in type 2 diabetesTheodore P Ciaraldi, Sunder Mudaliar, Ario Barzin, et al.Pageof 7